TY - JOUR T1 - ABERRANT IMMUNE PROGRAMMING IN NEUTROPHILS IN CYSTIC FIBROSIS JF - medRxiv DO - 10.1101/2023.01.22.23284619 SP - 2023.01.22.23284619 AU - Yawen Hu AU - Christine M. Bojanowski AU - Clemente J. Britto AU - Dianne Wellems AU - Kejing Song AU - Callie Scull AU - Scott Jennings AU - Jianxiong Li AU - Jay K. Kolls AU - Guoshun Wang Y1 - 2023/01/01 UR - http://medrxiv.org/content/early/2023/01/25/2023.01.22.23284619.abstract N2 - Cystic fibrosis (CF) is a life-shortening genetic disorder, caused by mutations in the gene that encodes Cystic Fibrosis Transmembrane-conductance Regulator (CFTR), a cAMP-activated chloride and bicarbonate channel. Although multiple organ systems can be affected, CF lung disease claims the most morbidity and mortality due to chronic bacterial infection, persistent neutrophilic inflammation, and mucopurulent airway obstruction. Despite the clear predominance of neutrophils in these pathologies, how CFTR loss-of-function affects these cells per se remains incompletely understood. Here, we report the profiling and comparing of transcriptional signatures of peripheral blood neutrophils from CF participants and healthy human controls (HC) at the single-cell level. Circulating CF neutrophils had an aberrant basal state with significantly higher scores for activation, chemotaxis, immune signaling, and pattern recognition, suggesting that CF neutrophils in blood are prematurely primed. Such an abnormal basal state was also observed in neutrophils derived from an F508del-CF HL-60 cell line, indicating an innate characteristic of the phenotype. LPS stimulation drastically shifted the transcriptional landscape of HC circulating neutrophils towards a robust immune response, however, CF neutrophils were immune-exhausted. Moreover, CF blood neutrophils differed significantly from CF sputum neutrophils in gene programming with respect to neutrophil activation and aging, as well as inflammatory signaling, highlighting additional environmental influences on the neutrophils in CF lungs. Taken together, loss of CFTR function has intrinsic effects on neutrophil immune programming that leads to premature priming and dysregulated response to challenge.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants to GW from The National Institutes of Health (HL150370) and The Cystic Fibrosis Foundation (WANG18I0) and by the Gilead Research Scholar Program in Cystic Fibrosis to CMB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The experimental design was approved by the Institutional Review Boards of Tulane University Health Sciences Center and Louisiana State University Health Sciences Center, Louisiana State, USA.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll scRNA-seq data have been deposited in the Gene Expression Omnibus (GEO) database. The human blood neutrophil data (CF patients and healthy controls) are under the accession code (GSE220658), and the HL-60-derived neutrophil data are under the accession code (GSE220913). ER -